fragmin 2.500 i.e./0,2 ml raztopina za injiciranje
pfizer luxembourg sarl - natrijev dalteparinat - raztopina za injiciranje - natrijev dalteparinat 12500 i.e. / 1 ml - dalteparin
fragmin 15.000 i.e./0,6 ml raztopina za injiciranje
pfizer luxembourg sarl - natrijev dalteparinat - raztopina za injiciranje - natrijev dalteparinat 25000 i.e. / 1 ml - dalteparin
fragmin 12.500 i.e./0,5 ml raztopina za injiciranje
pfizer luxembourg sarl - natrijev dalteparinat - raztopina za injiciranje - natrijev dalteparinat 25000 i.e. / 1 ml - dalteparin
rifinah 150 mg/100 mg obložene tablete
sanofi-aventis d.o.o. - izoniazid; rifampicin - obložena tableta - izoniazid 100 mg / 1 tableta rifampicin150 mg / 1 tableta; rifampicin 150 mg / 1 tableta - rifampicin in izoniazid
rifinah 300 mg/150 mg obložene tablete
sanofi-aventis d.o.o. - izoniazid; rifampicin - obložena tableta - izoniazid 150 mg / 1 tableta rifampicin300 mg / 1 tableta; rifampicin 300 mg / 1 tableta - rifampicin in izoniazid
rifater 50 mg/120 mg/300 mg obložene tablete
sanofi-aventis d.o.o. - izoniazid; pirazinamid; rifampicin - obložena tableta - izoniazid 50 mg / 1 tableta pirazinamid300 mg / 1 tableta rifampicin120 mg / 1 tableta; pirazinamid 300 mg / 1 tableta rifampicin120 mg / 1 tableta; rifampicin 120 mg / 1 tableta - rifampicin, pirazinamid in izoniazid
voltaren forte 50 mg filmsko obložene tablete
pliva ljubljana d.o.o., ljubljana - natrijev diklofenakat - filmsko obložena tableta - natrijev diklofenakat 50 mg / 1 tableta - diklofenak
voltaren retard 100 mg filmsko obložene tablete s podaljšanim sproščanjem
pliva ljubljana d.o.o., ljubljana - natrijev diklofenakat - tableta s podaljšanim sproščanjem - natrijev diklofenakat 100 mg / 1 tableta - diklofenak
fragmin 10.000 i.e./1 ml raztopina za injiciranje
pfizer luxembourg sarl - natrijev dalteparinat - raztopina za injiciranje - natrijev dalteparinat 10000 i.e. / 1 ml - dalteparin
zydelig
gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.